Abdominal Aortic Aneurysm
Study data from Tampere University provide new insights into abdominal aortic aneurysm
Published in Cardiovascular Device Liability Week, August 3rd, 2008
"The aim of our study was to describe the effects of levosimendan on systemic and splanchnic circulation during and after abdominal aortic surgery. Twenty abdominal aortic aneurysm surgery patients were randomized to receive either levosimendan (n = 10) or placebo (n = 10) in a double-blinded manner. Both the mode of anaesthesia and the surgical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Heart Disease
New heart disease findings from G.A. Mensah and co-authors described - Life Sciences
University of California, Department of Medicine publishes research in life sciences - The Committee to Protect Dogs
State's Highest Court Unanimously Rejects Dog Track Lawsuit - Abdominal Aortic Aneurysm Immunology
Research from Uppsala University, Department of Surgical Sciences has provided new information about abdominal aortic aneurysm immunology - Acute Ischemia
Research on acute ischemia published by scientists at Mayo Clinic - Adverse Drug Reactions
New adverse drug reactions research has been reported by scientists at University of Dusseldorf - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
